Cargando…
Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management
Lung cancer is the leading cause of cancer-related deaths worldwide. Despite growing efforts for its early detection by screening populations at risk, the majority of lung cancer patients are still diagnosed in an advanced stage. The management of lung cancer has dramatically improved in the last de...
Autores principales: | Šutić, Maja, Vukić, Ana, Baranašić, Jurica, Försti, Asta, Džubur, Feđa, Samaržija, Miroslav, Jakopović, Marko, Brčić, Luka, Knežević, Jelena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624402/ https://www.ncbi.nlm.nih.gov/pubmed/34834454 http://dx.doi.org/10.3390/jpm11111102 |
Ejemplares similares
-
Neutrophil-to-lymphocyte Ratio can Predict Outcome in Extensive-stage Small Cell Lung Cancer
por: Drpa, Gordana, et al.
Publicado: (2020) -
CpG islands in MyD88 and ASC/PYCARD/TMS1 promoter regions are differentially methylated in head and neck squamous cell carcinoma and primary lung squamous cell carcinoma
por: Šutić, Maja, et al.
Publicado: (2021) -
TLR5 Variants Are Associated with the Risk for COPD and NSCLC Development, Better Overall Survival of the NSCLC Patients and Increased Chemosensitivity in the H1299 Cell Line
por: Baranašić, Jurica, et al.
Publicado: (2022) -
Angiotensin-Converting Enzyme 2 (ACE2) as a Potential Diagnostic and Prognostic Biomarker for Chronic Inflammatory Lung Diseases
por: Marčetić, Dejan, et al.
Publicado: (2021) -
Association of NLRP1 Coding Polymorphism with Lung Function and Serum IL-1β Concentration in Patients Diagnosed with Chronic Obstructive Pulmonary Disease (COPD)
por: Ozretić, Petar, et al.
Publicado: (2019)